BPC Arginate Dosage Guide: How Much to Take and When (2026)

BPC Arginate is one of the most researched peptides in sports and longevity communities. But finding clear, honest information on how much to take — and when — is harder than it should be.

This guide covers what the research actually says about BPC Arginate dosing, how to think about the arginate vs. acetate difference, and why the salt form you choose affects more than just the label on the bottle.

Important: BPC Arginate is a research compound. The information below is educational. It is not medical advice, and BPC Arginate is not FDA-approved for human use.

What Is BPC Arginate and Why Does Dosage Matter?

BPC Arginate (Body Protective Compound) is a synthetic pentadecapeptide — a chain of 15 amino acids — first isolated from human gastric juice by Croatian researcher Predrag Sikirić and colleagues in the early 1990s. Its sequence is: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.

What makes dosage critical with BPC Arginate is the fact that virtually all published research is in animal models — primarily rats and mice. Translating those doses to humans requires understanding allometric scaling, and even then, there are no confirmed human clinical trials yet. Any dosing range you see is either extrapolated from animal data or reported anecdotally by researchers and biohackers.

What Animal Research Tells Us About BPC Arginate Dosing

The peer-reviewed literature shows a wide range of effective doses depending on the condition being studied:

• Tendon and ligament repair: Studies by Sikirić et al. and others used doses of 10 mcg/kg bodyweight intraperitoneally in rats, showing accelerated healing of Achilles tendon, medial collateral ligament, and rotator cuff injuries.
• Gastric ulcer protection: Doses as low as 1–5 mcg/kg showed significant gastroprotective effects in NSAID-induced ulcer models.
• Systemic anti-inflammatory effects: 10 mcg/kg doses showed reduction in inflammatory markers across multiple studies.
• Neurological studies: Effective doses ranged from 1–10 mcg/kg depending on outcome.

Using the standard FDA allometric scaling method (Km factor: rat Km = 6, human Km = 37), a rat dose of 10 mcg/kg translates to a human equivalent dose of approximately 1.6 mcg/kg — roughly 114 mcg for a 70 kg adult. The 250–500 mcg commonly discussed in research communities runs 2–4x above this scaled estimate, though extrapolation from rodents to humans carries significant uncertainty in either direction.

Community Dosing Ranges (Anecdotal / Research Context)

Among researchers and biohackers who have documented their experiences publicly, the most frequently reported oral dosing range is:

• Low range: 200–250 mcg per day
• Standard range: 400–500 mcg per day
• Higher range: 500–1000 mcg per day (typically for acute injury protocols)

These numbers appear regularly across research-oriented communities, but they are not validated by human clinical trials. The body of evidence is promising but still preclinical.

Arginate vs. Acetate: Does the Salt Form Change the Dose?

Most earlier BPC Arginate research was conducted using the acetate salt form. In recent years, the arginate salt form has become increasingly available — and for good reason.

Here is what the salt form difference actually means for dosing:

Stability

The acetate salt uses acetic acid (the same compound that gives vinegar its smell) as the counter-ion. This form is less stable at room temperature and more sensitive to heat and moisture. The arginate form uses arginine — a naturally occurring amino acid — as the counter-ion, resulting in greater molecular stability and a longer shelf life under typical storage conditions.

Oral Bioavailability (Theoretical)

Peptides face significant degradation in the gastrointestinal tract, which is why injectable forms have traditionally been favored in research settings. The arginate salt's improved stability means less degradation before absorption is theoretically possible. No direct human comparative bioavailability studies have been published yet, but the chemistry supports the hypothesis that arginate may deliver more intact peptide per oral dose.

Practical Implication

If you are using the acetate form orally and switching to arginate, some researchers suggest the effective dose could be achieved at the lower end of the standard range. The more stable the peptide when it reaches absorption sites, the less quantity you may need to achieve the same effect. That said, this remains theoretical for oral administration.

Our BPC Arginate (120ct) delivers 500 mcg per capsule in the arginate salt form, Janoshik third-party tested for purity and accurate peptide content.

Timing: When to Take BPC Arginate

Because no human pharmacokinetics data exists for oral BPC Arginate, timing recommendations are based on animal data and community reports:

Morning (Fasted)

Taking BPC Arginate on an empty stomach reduces the amount of protein and enzymatic activity competing for absorption in the GI tract. Many researchers prefer this window for this reason.

Split Dosing

Some researchers using 500 mcg or more per day split into two 250 mcg doses — morning and evening — to maintain a more consistent presence in the bloodstream throughout the day.

Around Training

For musculoskeletal applications specifically, some research protocols time administration around training sessions, either pre- or post-workout. There is no strong evidence establishing an optimal window here; consistency matters more than exact timing.

Cycle Length

Animal studies run from a few days to 12 weeks depending on the model. In community practice, researchers typically run oral protocols for 4–12 weeks before taking a break. There are no published data on long-term safety in humans, and cycling is a reasonable precaution given the current state of evidence.

What to Watch For

In animal studies, BPC Arginate has shown a strong safety profile with no reported toxic dose. In the broader research community, commonly reported observations include:

• Improved sleep quality (positive)
• Faster recovery from training (positive)
• Reduced joint discomfort (positive)
• Mild fatigue in the first few days of a new protocol (temporary, reported by some)

No serious adverse events have been documented in the published animal literature. However, human clinical data is absent, and individual responses vary.

The Bottom Line on BPC Arginate Dosing

There is no FDA-approved dosing protocol for BPC Arginate in humans. The most defensible approach based on available evidence is:

1. Start at the lower end of the reported range (200–250 mcg/day)
2. Use the arginate salt form for greater stability and theoretical oral bioavailability advantages
3. Be consistent with timing — morning, fasted is a reasonable default
4. Run defined cycles (4–8 weeks) with breaks rather than indefinite daily use
5. Source from suppliers who provide third-party certificates of analysis confirming peptide identity and purity

If you are considering BPC Arginate, the arginate form is the logical starting point. Wise Choice Supplements BPC Arginate (120ct) is Janoshik-verified at 500 mcg per capsule — so you know exactly what you are getting.

This article is for educational purposes only. BPC Arginate is a research peptide not approved by the FDA for human use. Consult a qualified healthcare provider before starting any new supplement or peptide protocol.